Keyphrases
Contraceptives
100%
Mifepristone
100%
Megestrol Acetate
100%
Sequential Regimen
100%
Bleeding
66%
Monophasic
66%
Follicle Rupture
66%
Ovulation
33%
Contraceptive Use
33%
Adverse Reactions
33%
Endometrial Biopsy
33%
Treatment Cycle
33%
Phase II Clinical Trial
33%
Withdrawal Bleeding
33%
Secretory Endometrium
33%
Treatment Effect
33%
Ovulatory Cycle
33%
Ovarian Ultrasonography
33%
Progesterone Rise
33%
Medicine and Dentistry
Mifepristone
100%
Nomegestrol Acetate
100%
Bleeding
66%
Volunteer
33%
Clinical Trial
33%
Progesterone
33%
Adverse Event
33%
Endometrium
33%
Endometrial Biopsy
33%
Menstrual Cycle
33%
Ovulation
33%
Echography
33%
Withdrawal Bleeding
33%
Pharmacology, Toxicology and Pharmaceutical Science
Mifepristone
100%
Nomegestrol Acetate
100%
Bleeding
66%
Adverse Event
33%
Progesterone
33%
Clinical Trial
33%
Withdrawal Bleeding
33%